The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment

References

• WHO Media centre. Malaria. Fact sheet, (2015).
   Google Scholar
• Tan, KR, Magill, AJ, Parise, ME, Arguin, PM Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 2011; 84:517-31; PMID:21460003; http://dx.doi.org/10.4269/ajtmh.2011.10-0285
   PubMed Web of Science ®Google Scholar
• Esu E, Effa EE, Opie ON, Uwaoma A, Meremikwu MM.Artemether for severe malaria. Cochrane database Syst Rev 2014; 9:CD010678; PMID:25209020
   PubMedGoogle Scholar
• Eastman, RT, Fidock, DA Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 2009; 7:864-74; PMID:19881520
   PubMed Web of Science ®Google Scholar
• White NJ Qinghaosu (artemisinin): the price of success. Science 2008 320:330-4; PMID:18420924; http://dx.doi.org/10.1126/science.1155165
   PubMed Web of Science ®Google Scholar
• Gardner, MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002; 419:498-511; PMID:12368864; http://dx.doi.org/10.1038/nature01097
   PubMed Web of Science ®Google Scholar
• Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J Biol Chem 2001; 276:47387-93; PMID:11584022; http://dx.doi.org/10.1074/jbc.M109089200
   PubMed Web of Science ®Google Scholar
• Istvan ES, Dharia NV, Bopp SE, Gluzman I, Winzeler EA, Goldberg DE. Validation of isoleucine utilization targets in Plasmodium falciparum. Proc Natl Acad Sci U S A 2011; 108:1627-32; PMID:21205898; http://dx.doi.org/10.1073/pnas.1011560108
   PubMed Web of Science ®Google Scholar
• Casewell MW, Hill RL. Mupirocin (‘pseudomonic acid’)–a promising new topical antimicrobial agent. J Antimicrob Chemother 1987; 19:1-5; PMID:3104272; http://dx.doi.org/10.1093/jac/19.1.1
   PubMed Web of Science ®Google Scholar
• Keller TL, Zocco D, Sundrud MS, Hendrick M, Edenius M, Yum J, Kim YJ, Lee HK, Cortese JF, Wirth DF, et al. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. Nat Chem Biol 2012; 8:311-7; PMID:22327401; http://dx.doi.org/10.1038/nchembio.790
   PubMed Web of Science ®Google Scholar
• Derbyshire ER, Mazitschek R, Clardy J. Characterization of Plasmodium liver stage inhibition by halofuginone. Chem Med Chem 2012; 7:844-9; PMID:22438279; http://dx.doi.org/10.1002/cmdc.201200045
   PubMed Web of Science ®Google Scholar
• Zhu S, Wang J, Chandrashekar G, Smith E, Liu X, Zhang Y. Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents. Eur J Med Chem 2010; 45:3864-9; PMID:20538379; http://dx.doi.org/10.1016/j.ejmech.2010.05.040
   PubMed Web of Science ®Google Scholar
• Zhu S, Chandrashekar G, Meng L, Robinson K, Chatterji D. Febrifugine analogue compounds: synthesis and antimalarial evaluation. Bioorg Med Chem 2012; 20:927-32; PMID:22182577; http://dx.doi.org/10.1016/j.bmc.2011.11.053
   PubMed Web of Science ®Google Scholar
• Zhou H, Sun L, Yang X-L, Schimmel P. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase. Nature 2013; 494:121-4; PMID:23263184; http://dx.doi.org/10.1038/nature11774
   PubMed Web of Science ®Google Scholar
• Scott PM, Van Walbeek W, MacLean WM Cladosporin, a new antifungal metabolite from Cladosporium cladosporioides. J Antibiot (Tokyo) 1971; 24:747-55; PMID:5169000; http://dx.doi.org/10.7164/antibiotics.24.747
   PubMed Web of Science ®Google Scholar
• Kimura Y, Shimomura N, Tanigawa F, Fujioka S, Shimada A. Plant growth activities of aspyran, asperentin, and its analogues produced by the fungus Aspergillus sp. Z Naturforsch C 2012; 67:587-93; PMID:23413753; http://dx.doi.org/10.5560/ZNC.2012.67c0587
   PubMed Web of Science ®Google Scholar
• Springer, JP, et al. Plant growth regulatory effects and stereochemistry of cladosporin. J Agric Food Chem 1981; 29:853-5; http://dx.doi.org/10.1021/jf00106a044
   Web of Science ®Google Scholar
• Anke H. Metabolic products of microorganisms. 184. On the mode of action of cladosporin. J Antibiot (Tokyo) 1979; 32:952-8; PMID:511784; http://dx.doi.org/10.7164/antibiotics.32.952
   PubMed Web of Science ®Google Scholar
• Miller JD, Sun M, Gilyan A, Roy J, Rand TG. Inflammation-associated gene transcription and expression in mouse lungs induced by low molecular weight compounds from fungi from the built environment. Chem Biol Interact 2010; 183:113-24; PMID:19818335; http://dx.doi.org/10.1016/j.cbi.2009.09.023
   PubMed Web of Science ®Google Scholar
• Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrián F, Matzen JT, Anderson P, et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A 2008; 105:9059-64; PMID:18579783; http://dx.doi.org/10.1073/pnas.0802982105
   PubMed Web of Science ®Google Scholar
• Hoepfner D, McNamara CW, Lim CS, Studer C, Riedl R, Aust T, McCormack SL, Plouffe DM, Meister S, Schuierer S, et al. Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin. Cell Host Microbe 2012; 11:654-663; PMID:22704625; http://dx.doi.org/10.1016/j.chom.2012.04.015
   PubMed Web of Science ®Google Scholar
• Sharma A, Khan S, Sharma A, Belrhali H, Yogavel M Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin. J Struct Funct Genomics 2014; 15:63-71; PMID:24935905; http://dx.doi.org/10.1007/s10969-014-9182-1
   PubMedGoogle Scholar
• Novoa EM, Ribas de Pouplana, L. Cooperation for Better Inhibiting. Chem Biol 2015; 22:685-6; PMID:26091164; http://dx.doi.org/10.1016/j.chembiol.2015.06.002
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhao C, Fang B, Jing P, Yang J, Xie X, She X. Asymmetric total synthesis of cladosporin and isocladosporin. J Org Chem 2012; 77:5656-63; PMID:22663064; http://dx.doi.org/10.1021/jo300805n
   PubMed Web of Science ®Google Scholar
• Bhatt TK, Kapil C, Khan S, Jairajpuri MA, Sharma V, Santoni D, Silvestrini F, Pizzi E, Sharma A. A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum. BMC Genomics 2009; 10:644; PMID:20042123; http://dx.doi.org/10.1186/1471-2164-10-644
   PubMed Web of Science ®Google Scholar
• Khan S, Sharma A, Jamwal A, Sharma V, Pole AK, Thakur KK, Sharma A. Uneven spread of cis- and trans-editing aminoacyl-tRNA synthetase domains within translational compartments of P. falciparum. Sci Rep 2011; 1:1-11; PMID:22355703; http://dx.doi.org/10.1038/srep00188
   PubMed Web of Science ®Google Scholar
• Jackson KE, Pham JS, Kwek M, De Silva NS, Allen SM, Goodman CD, McFadden GI, Ribas de Pouplana L, Ralph SA. Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum. Int J Parasitol 2012; 42:177-86; PMID:22222968; http://dx.doi.org/10.1016/j.ijpara.2011.11.008
   PubMed Web of Science ®Google Scholar
• Pham JS, Sakaguchi R, Yeoh LM, De Silva NS, McFadden GI, Hou YM, Ralph SA. A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys. Biochem J 2014; 458:513-23; PMID:24428730; http://dx.doi.org/10.1042/BJ20131451
   PubMed Web of Science ®Google Scholar
• Paetz W, Nass G. Biochemical and immunological characterization of threonyl-tRNA synthetase of two borrelidin-resistant mutants of Escherichia coli K12. Eur J Biochem 1973; 35:331-7; PMID:4577856; http://dx.doi.org/10.1111/j.1432-1033.1973.tb02843.x
   PubMedGoogle Scholar
• Otoguro K, Ui H, Ishiyama A, Kobayashi M, Togashi H, Takahashi Y, Masuma R, Tanaka H, Tomoda H, Yamada H, et al. In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia. J Antibiot (Tokyo) 2003; 56:727-9; PMID:14563165; http://dx.doi.org/10.7164/antibiotics.56.727
   PubMed Web of Science ®Google Scholar
• Ruan B, Bovee ML, Sacher M, Stathopoulos C, Poralla K, Francklyn CS, Söll D. A unique hydrophobic cluster near the active site contributes to differences in borrelidin inhibition among threonyl-tRNA synthetases. J Biol Chem 2005; 280:571-7; PMID:15507440; http://dx.doi.org/10.1074/jbc.M411039200
   PubMed Web of Science ®Google Scholar
• Fang P, Yu X, Jeong SJ, Mirando A, Chen K, Chen X, Kim S, Francklyn CS, Guo M. Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase. Nat Commun 2015; 6:6402; PMID:25824639; http://dx.doi.org/10.1038/ncomms7402
   PubMed Web of Science ®Google Scholar
• Novoa EM, Camacho N, Tor A, Wilkinson B, Moss S, Marín-García P, Azcárate IG, Bautista JM, Mirando AC, Francklyn CS, et al. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo. Proc Natl Acad Sci 2014; 111:E5508-17; PMID:NOT_FOUND; http://dx.doi.org/10.1073/pnas.1405994111
   PubMedGoogle Scholar
• Azcárate IG, Marín-García P, Camacho N, Pérez-Benavente S, Puyet A, Diez A, Ribas de Pouplana L, Bautista JM. Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin. Br J Pharmacol 2013; 169:645-58; PMID:Can't; http://dx.doi.org/10.1111/bph.12156
   PubMed Web of Science ®Google Scholar
• Sugawara A, Tanaka T, Hirose T, Ishiyama A, Iwatsuki M, Takahashi Y, Otoguro K, Ōmura S, Sunazuka T. Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against Plasmodium falciparum parasites. Bioorg Med Chem Lett 2013; 23:2302-5; PMID:23499502; http://dx.doi.org/10.1016/j.bmcl.2013.02.075
   PubMed Web of Science ®Google Scholar